“…Whether the same preventive tools may be used for both men and women, why we should not use on men the same validated diagnostic tools which are currently used on women, optimizing them according to gender? In female population, FDA-approved liquid-based cytology (LBC) is widely used to detect cervical abnormalities and, together with HPV-DNA test, has proven to be effective in reducing the burden of cervical cancer disease [14]. Moreover, E6/E7 mRNA testing, with its high level of specificity, is able to prevent overtreatment by stratifying the risk [14].…”